Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0004
-0.0002 (-33.33%)
Sep 8, 2026, 3:56 PM EST
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $217.49 thousand as of September 8, 2026. Its market cap has decreased by -89.19% in one year.
Market Cap
217.49K
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 217.49K, a decrease of -99.81%. That is a compound annual growth rate of -30.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 217.49K | -84.62% |
| Dec 31, 2025 | 1.41M | 420.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 458.51K |
| Nextel Medical | 441.93K |
| Mosaic ImmunoEngineering | 441.77K |
| Altamira Therapeutics | 405.80K |
| Actavia Life Sciences | 385.91K |
| Lyra Therapeutics | 354.98K |
| Orgenesis | 320.45K |
| MetaStat | 319.73K |